Matthews International posts steady quarter with flat sales and strong Propelis synergies boosting value.

Matthews International reported a solid quarter, maintaining flat organic sales in its Memorialization segment despite industry volume challenges. The Propelis unit, with a $130 million EBITDA run rate and ongoing synergy realization, significantly supports the company's valuation, with plans to divest it within 18 to 24 months. The Industrial Tech segment shows promising signs, including resumed commercial launches, legal patent wins, and a backlog exceeding $100 million. Matthews is strengthening its position through deleveraging and accretive acquisitions, though further improvements in cost of capital and Industrial Tech execution could enhance investor confidence.